s6y
Company name or ticker
Search
VERTEX PHARMACEUTICALS INC / MA
4
van Grunsven Jasper: Statement of changes in beneficial ownership of securities
Filed
Thursday, September 10, 2026
Period
Sep 8, 2026
Accession number
0000875320-26-000272
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header